Trending
December 16, 2024
December 8, 2024
November 30, 2024
The majority of us are unaware of the magical things that are constantly happening around us. These experiences sometimes are life changing which happens to changes us and the world around us. As we move forward in this article, we shall read and understand about regeneration and stem cell theory. Honestly, this topic of regeneration and stem cell theory is alien to most of us or have little to no knowledge about how it works.
As aforementioned, life-changing experiences hold the power to alter the world around us for better. The founder of Kintaro Cell Power, Alexei Gladkov went through one such experience. The inspiring journey of Kintaro began in 2011, when he was diagnosed with a severe heart condition. Soon, he was introduced to the regenerative powers of stem cells at one of Russia’s best medical research institutions. Alexei personally experienced the benefits of stem cell treatment and with his condition completely improving, he decided on a mission to bring this innovative medical technology to the world.
His experience led to the establishment of Kintaro Cell Power in 2011. The company adapts stem cell technology from Russia’s leading research institution MRRC (Medical Radiological Research Centre). The first Kintaro Cell Power was set up in Singapore before relocating to its current headquarters in Tokyo.
Initially, Kintaro Cell Power started its journey in Singapore introducing aged old Soviet research. The plan didn’t go as expected, soon, the company faced numerous obstacles. This made Alexei and team to move to Japan as they saw a more progressive and welcoming environment there. Japan was embracing cellular therapy. This shift worked in favour of the company as within a span of 10 years, it managed to widened its network in Asia, establishing a strong team of professionals and offices in every major city. The company has being consistent with its mission to bring high quality allogenic stem cells treatment to the world by using Japanese technology of robotization and automation.
Alexei and the team appreciates how Japanese technology has helped the company to work towards its mission. Moreover, Japan has been at the forefront of cellular treatment, being one of the first to approve and accept regenerative medicine. It has a progressive system that is more friendly to regenerative medicine. The friendly approach towards regenerative medicines allows Kintaro Cell Power to bring superior Japanese technology to the world. Led by the company’s vision and motto, the team has consistently showcased the true values of a processive company. The team has managed to deliver excellent services embedding quality, innovation, knowledge, trust, responsibility and integrity.
Since its inception, Kintaro Cell Power has been focusing on its primary goal i.e., to rejuvenate, increase life expectancy and improve the quality of life for everyone. Alongside the primary goal, Alexei wants to share the goodness of the stem cell technology that has helped him to lead a healthy and successful life. Further, he states, “I want to do all I can to heal the world. I was fortunate to get acquainted with this technology through a personal experience and from then on my thoughts were let’s take this to the world starting with South East Asia where we have been operating from the last 10 years.”
With aim to provide best services affiliating world class technology, Kintaro Cell Powers uses mesenchymal stem cells from bone marrow, extracted from very healthy donors. It focuses on allogenic stem cells transplantation. KINTARO cells is the company’s world class laboratory and scientists’ culture and manufacture bone marrow-derived mesenchymal stem cells which is combined by the reputable Russian research and the most advanced Japanese cell culture technology.
This very amalgamation of technology and experience allows the company to perform the process with high efficiency and smoothness. Moreover, Live cells are cultivated in its laboratories and injected fresh in the recipients within 48 hours of harvesting. As it is said quality attracts more consumers, Kintaro Cells Power adheres by this mantra. The products offered by the company are certified by medical professionals at Tokyo Medical University ensuring only the highest quality of mesenchymal stem cells are produced according to international safety standards. Kintaro Cells Power has amassed more than 50 certificates and patents, gaining credibility with medical institutions worldwide.
The future path of any company decides on how deeply it is involved in the research especially in the industries like biotech. Kintaro Cell Powers have been consistent in finding ways increase the swiftness with the technology and automation. It has prioritized and concentrated 100 percent on the results of the patients treated. It is on this premise that the company has stood strong over the years. This has allowed them to push the patients referral and patients partnership model. Aftermath, it has huge database of satisfied and repeat customers.
Moreover, as a leader in the industry, it strives to raise awareness of regenerative medicine and stem cell technology. As envisioned by Alexei, the company hugely invests in marketing and educating, which allows it to expand globally—starting with the Asian market. The company believes that in the coming years, Asian Market will see a surge in interest for stem cell therapy. At present, the company is in an advanced stage of developing robotization and automation for the manufacture of stem cell culture technology.
Alexei and the team believes that the future of Kintaro is robotization and automation with the use of artificial intelligence. It also believes with robotization it will expedite the regulatory approval process and makes cellular therapy more acceptable. As an advanced biotechnology company, Kintaro Cells Power is working to further refine its research and development capabilities, to take on the challenge of developing higher quality and highly functional stem cell treatments.
The cornerstone of the company was based on the Alexei’s vision to provide quality services and aware the world about the benefits of biotechnology. Noticeably, the company has fulfilled his dream of making cellular therapy accessible and affordable to everyone without compromising the quality, ensuring consistency and avoiding human error. Furthermore, Kintaro Cells Power aims to become a leader in the robotization of Japanese patented products and cell culture. In Japan, Kintaro Cells Power continues to work closely with Tokyo Medical University to conduct joint research and discover ways to pursue new research areas. “My next goal and one that I am currently working on earnestly is to take the technology one step further from manual production to automatic robotizations to achieve high and consistent quality and making it affordable to the masses,” states Alexei.
Currently, Kintaro Cell Power is working on building robotic laboratories around the world and in Japan. On October 6th 2020, the company inaugurated its own private Research Lab facility in Hokkaido. It is an original project rich in Japanese heritage and architecture. For building the lab, the company has focused on using traditional Japanese style stone storage and the designing for the main office is a traditional style folk house. Additionally, it will be opening its own, first in Japan, a Cells Shrine to pray for human health and happiness through regenerative and cellular medicine development. Also, the company has started building its own cell manufacture site in Ukraine as a base for Europe expansion plans.
The ongoing pandemic has definitely raised alarms for the world. This also means the world is more prepared than ever. In last few months, the level of awareness about health has increased; people are reading and searching more about the healthcare. Also, cellular therapy has been quite prominent in prevention and recovery for COVID. Alexei states, “We are seeing a surge in interest tremendously during COVID with more enquiries coming in from every part of the world. COVID has been good for regenerative medicine.”
Hence, the team of Kintaro Cell Power has been busy conducting online talks and seminars to constantly educate the public on cellular therapy and how it can help fight many forms of illnesses. The company is now preparing for “post-corona’ world and a series of activities. Also, now that the world is gradually reopening—with restrictions, the team will be looking at starting Medical Tourism business model in Nepal. The company has negotiations with local governments of Hokkaido and Okinawa in Japan to start “ special medical zone” in-bound medical tourism for rich Asians in 2022.
